Co-amilofruse
Jump to navigation
Jump to search
Combination of | |
---|---|
Amiloride | Potassium-sparing diuretic |
Furosemide | Loop diuretic |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
ChemSpider |
|
(what is this?) (verify) |
Co-amilofruse (BAN) is a nonproprietary name used to denote a combination of amiloride and furosemide, which are both diuretics.[1] Co-amilofruse is a treatment for fluid retention (oedema), either in the legs (peripheral edema) or on the lungs (pulmonary oedema). Furosemide is a loop diuretic and is more effective than amiloride, but has a tendency to cause low potassium levels (hypokalaemia); the potassium-sparing effects of amiloride may balance this.
Formulation
Two strengths of co-amilofruse are available:
- 2.5 mg amiloride with 20 mg furosemide, BAN of Co-amilofruse 2.5/20 (brand name Frumil LS)
- 5 mg amiloride with 40 mg furosemide, BAN of Co-amilofruse 5/4-0 (brand name Frumil)
References
- ^ Hitchings A, Lonsdale D, Burrage D, Baker E (2014). Top 100 drugs : clinical pharmacology and practical prescribing. Edinburgh: Elsevier Health Sciences. p. 113. ISBN 978-0-7020-5515-7.
Categories:
- Chemicals that do not have a ChemSpider ID assigned
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes which contain changes to verified fields
- Drugs that are a combination of chemicals
- Loop diuretics
- Potassium-sparing diuretics
- Combination drugs
- All stub articles
- Cardiovascular system drug stubs